Vinpocetine for cognitive impairment and dementia-Reference-Cited by-同舟云学术

Vinpocetine for cognitive impairment and dementia

Published:2003-01-20 Issue:1 Volume:2010 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Szatmári Szabolcs¹,Whitehouse Peter²

Affiliation:

1. University of Medicine and Pharmacy Tg. Mures; Department of Neurology; Ghe Marinescu 38 Targu Mures Romania 540000

2. Center University Hospitals of Cleveland Room 357C, Fairhill Center; Department of Neurology; 122200 Fairhill Road Cleveland Ohio USA 44120

Publisher

Wiley

Subject

Pharmacology (medical)

Reference43 articles.

1. Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome;Blaha;Human Psychopharmacology,1989

2. Long-term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome;Fenzl,1986

3. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes;Hindmarch;International Clinical Psychopharmacology,1991

4. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction;Balestreri;Journal of the American Geriatrics Society,1987

5. Vinpotropile in the treatment of cerebral vascular diseases;Filimonov VA;Zh Nevrol Psikhiatr Im S S Korsakova,2007

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Approaches and Herbal Interventions for Alzheimer's Disease;The Natural Products Journal;2024-11

2. High rate of potentially inappropriate medication use in older people: a case–control study;GeroScience;2024-07-09

3. Pathophysiology and management of testicular ischemia/reperfusion injury: Lessons from animal models;Heliyon;2024-05

4. Determination of alkaloid-inspired molecule vindeburnol in rabbit plasma by UPLC–HRMS and its application to pharmacokinetic studies and preliminary metabolite identification;Journal of Pharmaceutical and Biomedical Analysis;2024-02

5. Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases;Medicinal Research Reviews;2024-01-27